Strode Comments on Wisdom of Strategic Hospital Acquisitions
26 July 2018
RevCycleIntelligence
Partner Roger Strode was quoted in a RevCycleIntelligence article, “When Should Providers Consider a Strategic Hospital Acquisition?” about the dangers of waiting too long to consider a strategic hospital acquisition that could benefit your facility and the health of your community.
Strode said many small hospitals mistakenly view remaining independent as a show of strength. “Long-term, that’s worse for their patients and for their communities,” he said. “They wait until they are running out of cash and they start looking like the Alamo. You don’t want to be in a position where Santa Anna’s army is completely surrounding you at that point. You really want to be in a position of strength when you negotiate with these systems.”
Strode said many small hospitals mistakenly view remaining independent as a show of strength. “Long-term, that’s worse for their patients and for their communities,” he said. “They wait until they are running out of cash and they start looking like the Alamo. You don’t want to be in a position where Santa Anna’s army is completely surrounding you at that point. You really want to be in a position of strength when you negotiate with these systems.”
People
Related News
13 February 2025
In the News
Gregory Husisian on USMCA Viability – 'The question is in what form?'
Foley & Lardner LLP partner Gregory Husisian assessed the viability of the U.S. – Mexico – Canada Agreement (USMCA) in the IndustryWeek article, “As Tariffs Concerns Grow, Where Is the USMCA?“
13 February 2025
In the News
Nikhil Pradhan on FDA Draft AI Drug Guidance – 'The industry is very much evolving'
Foley & Lardner LLP senior counsel Nikhil Pradhan shared insight on recent draft guidance from the U.S. Food and Drug Administration's in the MedCentral article, "FDA Draft Guidance Addresses Drug Submissions that Use AI Data."
12 February 2025
In the News